Ads by Google
USA Today examined how some pharmaceutical industry analysts cite more cautious regulators and less innovation by drug makers as reasons for the low rate of new drug approvals in 2007.
Mylan Pharmaceuticals has received final approval from FDA for its Abbreviated New Drug Application for Granisetron Hydrochloride Tablets.
FDA issued new information to health care professionals to alert them about an increased risk of suicidal thoughts and behaviors in patients who take drugs called antiepileptics.
Medicare prescription drug benefit in 2008 increased by 6.2% from last year to 25.4 million beneficiaries.
Consumers Union is collecting 50,000 signatures on a petition to FDA demanding the agency make it easier for patients to report problems with their medications.
A pharmaceutical plant in Uganda will begin production of generic antiretroviral drugs.
Health Sciences Authority of Singapore recalled this batch of RGC-RMC Rheumax Capsule as it was found to contain progesterone.
Health Sciences Authority of Singapore advised the public not to purchase or consume nine specific batches of these Chinese medicines and herbal teas.
Codexis introduced the Codex MicroCyp Plate, a research productivity tool which can be used by pharmaceutical companies to more rapidly identify and synthesize drug metabolites and novel drug lead candidates.
China Pharma Holdings has received approval from Chinese SFDA for the production of generic Bumetanide injection which is used to manage hypertension and edema.
European Commission has given approval for the Roche's significantly wider use of its anti-angiogenic agent Avastin in patients suffering from metastatic colorectal cancer.
Los Angeles Times examined how the business strategy that has made the pharmaceutical industry one of the wealthiest and most powerful on Earth might have begun to betray it.
Recent studies raised questions about the benefits of the cholesterol medication Vytorin.
Institute of Medicine called for the creation of a single, public database that gauges the effectiveness of drugs and health services.
DuPont has received federal registration approval from US Environmental Protection Agency for two corn herbicides: Resolve Q (mp) and Require Q (mp).
US Patent and Trademark Office rejected four patents on Gilead Sciences' antiretroviral drug Viread.
Wal-Mart plans to begin a pilot program under which the company will help certain employers manage how they process and pay prescription claims.
University students in America are turning to amphetamine-based prescription medications in overwhelming numbers to boost their focus, stay up late, and cram for finals. These meds, most often prescribed for Attention Deficit Hyperactivity Disorder (ADHD), can improve concentration but may also pose serious health risks.
FDA has approved Astellas Pharma's sNDA seeking approval for the use of MYCAMINE for Injection in the treatment of patients with Candidemia, Acute Disseminated Candidiasis, Candida Peritonitis and Abscesses.
International Cochrane Collaboration released a review of existing data on the efficacy of OTC cough medicines in children and adults.
With weak new product pipelines and sagging stock values, drug companies are increasingly relying on the government for revenue.
Consumers who pick up their prescription medications at a pharmacy drive-through window might be jeopardizing their own safety in the name of convenience.
Important health care innovations, such as medications and vaccines, may not be readily available to low-income people in developing countries.